182 related articles for article (PubMed ID: 18056348)
1. CD28 deficiency exacerbates joint inflammation upon Borrelia burgdorferi infection, resulting in the development of chronic Lyme arthritis.
Iliopoulou BP; Alroy J; Huber BT
J Immunol; 2007 Dec; 179(12):8076-82. PubMed ID: 18056348
[TBL] [Abstract][Full Text] [Related]
2. Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment.
Iliopoulou BP; Alroy J; Huber BT
Arthritis Rheum; 2008 Dec; 58(12):3892-901. PubMed ID: 19035513
[TBL] [Abstract][Full Text] [Related]
3. Emergence of chronic Lyme arthritis: putting the breaks on CD28 costimulation.
Iliopoulou BP; Huber BT
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):180-5. PubMed ID: 18792834
[TBL] [Abstract][Full Text] [Related]
4.
Jutras BL; Lochhead RB; Kloos ZA; Biboy J; Strle K; Booth CJ; Govers SK; Gray J; Schumann P; Vollmer W; Bockenstedt LK; Steere AC; Jacobs-Wagner C
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13498-13507. PubMed ID: 31209025
[TBL] [Abstract][Full Text] [Related]
5. NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi.
Tupin E; Benhnia MR; Kinjo Y; Patsey R; Lena CJ; Haller MC; Caimano MJ; Imamura M; Wong CH; Crotty S; Radolf JD; Sellati TJ; Kronenberg M
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19863-8. PubMed ID: 19060201
[TBL] [Abstract][Full Text] [Related]
6. Mercury exposure as a model for deviation of cytokine responses in experimental Lyme arthritis: HgCl2 treatment decreases T helper cell type 1-like responses and arthritis severity but delays eradication of Borrelia burgdorferi in C3H/HeN mice.
Ekerfelt C; Andersson M; Olausson A; Bergström S; Hultman P
Clin Exp Immunol; 2007 Oct; 150(1):189-97. PubMed ID: 17672870
[TBL] [Abstract][Full Text] [Related]
7. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.
Siitonen R; Pietikäinen A; Liljenbäck H; Käkelä M; Söderström M; Jalkanen S; Hytönen J; Roivainen A
Arthritis Res Ther; 2017 Nov; 19(1):254. PubMed ID: 29166944
[TBL] [Abstract][Full Text] [Related]
8. 5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis.
Blaho VA; Zhang Y; Hughes-Hanks JM; Brown CR
J Immunol; 2011 Mar; 186(5):3076-84. PubMed ID: 21270404
[TBL] [Abstract][Full Text] [Related]
9. Cimetidine as a novel adjunctive treatment for early stage Lyme disease.
Shemenski J
Med Hypotheses; 2019 Jul; 128():94-100. PubMed ID: 27107653
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling reveals unique pathways associated with differential severity of lyme arthritis.
Crandall H; Dunn DM; Ma Y; Wooten RM; Zachary JF; Weis JH; Weiss RB; Weis JJ
J Immunol; 2006 Dec; 177(11):7930-42. PubMed ID: 17114465
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
Grosenbaugh DA; Rissi DR; Krimer PM
Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
[TBL] [Abstract][Full Text] [Related]
12. Presence of Arp specifically contributes to joint tissue edema associated with early-onset Lyme arthritis.
Hove PR; Haldorson GJ; Magunda F; Bankhead T
Infect Immun; 2014 Jan; 82(1):43-51. PubMed ID: 24101694
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi.
Heilpern AJ; Wertheim W; He J; Perides G; Bronson RT; Hu LT
Infect Immun; 2009 Jul; 77(7):2643-9. PubMed ID: 19364840
[TBL] [Abstract][Full Text] [Related]
14. Role of aggrecanase 1 in Lyme arthritis.
Behera AK; Hildebrand E; Szafranski J; Hung HH; Grodzinsky AJ; Lafyatis R; Koch AE; Kalish R; Perides G; Steere AC; Hu LT
Arthritis Rheum; 2006 Oct; 54(10):3319-29. PubMed ID: 17009305
[TBL] [Abstract][Full Text] [Related]
15. Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity.
Anguita J; Barthold SW; Persinski R; Hedrick MN; Huy CA; Davis RJ; Flavell RA; Fikrig E
J Immunol; 2002 Jun; 168(12):6352-7. PubMed ID: 12055252
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of Lyme arthritis in mice by [
Pietikäinen A; Siitonen R; Liljenbäck H; Eskola O; Söderström M; Roivainen A; Hytönen J
Scand J Rheumatol; 2018 Jan; 47(1):37-47. PubMed ID: 28649922
[TBL] [Abstract][Full Text] [Related]
17. Mice lacking CD21 and CD35 proteins mount effective immune responses against Borrelia burgdorferi infection.
Jacobson AC; Ma Y; Zachary JF; Weis JJ; Weis JH
Infect Immun; 2007 Apr; 75(4):2075-8. PubMed ID: 17283093
[TBL] [Abstract][Full Text] [Related]
18. Infectious arthritis and immune dysregulation: lessons from Lyme disease.
Iliopoulou BP; Huber BT
Curr Opin Rheumatol; 2010 Jul; 22(4):451-5. PubMed ID: 20375899
[TBL] [Abstract][Full Text] [Related]
19. Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease.
Byram R; Gaultney RA; Floden AM; Hellekson C; Stone BL; Bowman A; Stevenson B; Johnson BJ; Brissette CA
Infect Immun; 2015 Sep; 83(9):3675-83. PubMed ID: 26150536
[TBL] [Abstract][Full Text] [Related]
20. Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice.
Nardelli DT; Luedtke JO; Munson EL; Warner TF; Callister SM; Schell RF
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):78-89. PubMed ID: 20662925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
